Questcor Finds Profit for Acthar Drug, at $28,000 a Vial

[unable to retrieve full-text content]After pricing its once-obscure drug, Acthar, in the stratosphere, Questcor gained many fans on Wall Street. But the company has also drawn some doubters.

Source: http://www.nytimes.com/2012/12/30/business/questcor-finds-profit-for-acthar-drug-at-28000-a-vial.html?partner=rss&emc=rss

London 2012 Fencing olympics chariots of fire nbc Medal Count Sam Mikulak London 2012 diving